The Irish Competition Authority issues enforcement decision regarding alleged anticompetitive actions by the body in charge of supplying drugs, medicines and medical appliances to the public (Health Services Executive)

Introduction The Health Services Executive (HSE) is a body established pursuant to the Health Act 2004. According to section 7(1) of that Act, the purpose of the HSE is to “use the resources available to it in the most beneficial, effective and efficient manner to improve, promote and protect the health and welfare of the public”. In order to achieve this objective the HSE is required to “manage and ...deliver, or arrange to be delivered on its behalf, health and personal social services”. More specifically section 59 of the Act imposes an obligation on the HSE to arrange for the supply of drugs, medicines and medical appliances to the general public [1]. In this regard, the HSE administers a scheme, the “Community Drugs Schemes”, the aim of which is to provide prescription drugs to the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • London School of Economics (London)

Quotation

Orla Lynskey, The Irish Competition Authority issues enforcement decision regarding alleged anticompetitive actions by the body in charge of supplying drugs, medicines and medical appliances to the public (Health Services Executive), 10 October 2008, e-Competitions October 2008, Art. N° 23007

Visites 1865

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues